Keywords: merck, co, goes, once-weekly, osteoporosis, drug, fosamax

Merck & Co goes once-weekly with osteoporosis drug Fosamax

Article | 24 November 1999

Print This

In a bid to retain its market lead, Merck & Co has developed aonce-weekly formulation of its blockbuster osteoporosis drug Fosamax ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in